Sleep Apnea Syndromes
Welcome,         Profile    Billing    Logout  
 18 Companies   33 Products   33 Products   37 Mechanisms of Action   1 Trial   994 News 


«12345678910111213...1920»
  • ||||||||||  Phase classification, Enrollment change:  Positive Airway Pressure for the Treatment of Asthma (clinicaltrials.gov) -  May 17, 2017   
    P=N/A,  N=31, Completed, 
    Completed --> Active, not recruiting | Trial primary completion date: Dec 2009 --> Dec 2025 Phase classification: P1/2 --> P=N/A | N=23 --> 31
  • ||||||||||  Enrollment closed, Trial primary completion date, HEOR, Cost effectiveness:  REST: MRA Therapy Versus CPAP Therapy in Moderate OSAS (clinicaltrials.gov) -  May 8, 2017   
    P=N/A,  N=86, Active, not recruiting, 
    N=700 --> 0 | Suspended --> Withdrawn Recruiting --> Active, not recruiting | Trial primary completion date: May 2017 --> Nov 2017
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date, Compliance:  Impact of Interface With/Without Oral Appliance of Sleep Apnea Treatment (clinicaltrials.gov) -  May 5, 2017   
    P=N/A,  N=15, Terminated, 
    Recruiting --> Active, not recruiting | Trial primary completion date: May 2017 --> Nov 2017 N=35 --> 15 | Recruiting --> Terminated | Trial primary completion date: Sep 2016 --> Jan 2017; Inability to further include additional patients
  • ||||||||||  Enrollment closed, Trial primary completion date:  Unrecognised Obstructive Sleep Apnea Study (clinicaltrials.gov) -  May 5, 2017   
    P=N/A,  N=400, Active, not recruiting, 
    N=35 --> 15 | Recruiting --> Terminated | Trial primary completion date: Sep 2016 --> Jan 2017; Inability to further include additional patients Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2017 --> Dec 2018
  • ||||||||||  Trial completion, Enrollment change, Surgery:  Semi-up Right Position Study (clinicaltrials.gov) -  May 4, 2017   
    P=N/A,  N=164, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2017 --> Dec 2018 Active, not recruiting --> Completed | N=56 --> 164
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Oxygen Supplementation Study in Obstructive Sleep Apnea (OSA) Patients (clinicaltrials.gov) -  May 4, 2017   
    P=N/A,  N=196, Completed, 
    Recruiting --> Completed | Trial primary completion date: Nov 2015 --> Feb 2017 Active, not recruiting --> Completed | N=156 --> 196 | Trial primary completion date: Dec 2016 --> Apr 2017
  • ||||||||||  carvedilol / Generic mfg., irbesartan / Generic mfg.
    Trial completion, Combination therapy:  Clinical Trial in Patients With Hypertension and Left Ventricular Dysfunction (clinicaltrials.gov) -  May 1, 2017   
    P=N/A,  N=100, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Sep 2017 Recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  The Role of Obstructive Sleep Apnea in Children With Fatty Liver Disease (clinicaltrials.gov) -  Apr 27, 2017   
    P=N/A,  N=1, Completed, 
    Recruiting --> Completed Recruiting --> Completed | N=15 --> 1 | Trial primary completion date: Jan 2018 --> Apr 2017
  • ||||||||||  Biomarker, Trial completion, Trial primary completion date:  Exhaled NO as a Biomarker of Gestational OSA and Persistence Postpartum (clinicaltrials.gov) -  Apr 20, 2017   
    P=N/A,  N=76, Completed, 
    Trial primary completion date: Sep 2016 --> Sep 2017 Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Nov 2016
  • ||||||||||  Biomarker, Trial completion, Enrollment change, Trial primary completion date:  BOSA: Biomarkers for Obstructive Sleep Apnea (clinicaltrials.gov) -  Apr 18, 2017   
    P=N/A,  N=181, Completed, 
    Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Nov 2016 Active, not recruiting --> Completed | N=40 --> 181 | Trial primary completion date: Oct 2016 --> Feb 2015
  • ||||||||||  eszopiclone / Generic mfg.
    Phase classification:  The Effect of Eszopiclone on the Arousal Threshold in Sleep Apnea Syndrome (clinicaltrials.gov) -  Apr 18, 2017   
    P,  N=17, Completed, 
    Active, not recruiting --> Completed | N=40 --> 181 | Trial primary completion date: Oct 2016 --> Feb 2015 Phase classification: P=N/A --> P
  • ||||||||||  Trial termination:  Neurocognitive Function in Snoring Children (clinicaltrials.gov) -  Apr 10, 2017   
    P=N/A,  N=40, Terminated, 
    N=20 --> 2 | Recruiting --> Terminated | Trial primary completion date: Aug 2017 --> Mar 2017; Recruitment rates too low Completed --> Terminated; PI left the university
  • ||||||||||  Trial completion, Trial primary completion date:  The Treatment of Obstructive Sleep Apnea With Continuous Positive Airway Pressure on Appearance and Age (clinicaltrials.gov) -  Mar 29, 2017   
    P=N/A,  N=30, Completed, 
    Recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Apr 2017; Sufficient follow-up information obtained to support study goals Recruiting --> Completed | Trial primary completion date: Sep 2016 --> Mar 2017
  • ||||||||||  Trial completion, Trial initiation date, HEOR, Cost effectiveness:  Home Nasal Pressure for Sleep Apnea Management in Primary Case (clinicaltrials.gov) -  Mar 15, 2017   
    P=N/A,  N=280, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | Initiation date: Mar 2016 --> Mar 2014
  • ||||||||||  hydrocodone/paracetamol / Generic mfg., ibuprofen / Generic mfg.
    Enrollment change, Trial termination:  Post-operative Pain Control After Pediatric Adenotonsillectomy (clinicaltrials.gov) -  Mar 10, 2017   
    P4,  N=53, Terminated, 
    Recruiting --> Completed N=100 --> 53 | Recruiting --> Terminated
  • ||||||||||  Enrollment change, Trial primary completion date, Surgery, Bariatric surgery:  Assessment of Sleep Apnea and Its Causes Before and After Weight Loss Surgery (clinicaltrials.gov) -  Mar 3, 2017   
    P=N/A,  N=10, Terminated, 
    Active, not recruiting --> Completed | N=1000 --> 1873 N=60 --> 10 | Trial primary completion date: Oct 2014 --> Jan 2017
  • ||||||||||  Egrifta (tesamorelin acetate) / Theratechnologies, Massachusetts General Hospital
    Enrollment change, Trial withdrawal:  Egrifta Replacement and Sleep Disordered Breathing (clinicaltrials.gov) -  Mar 3, 2017   
    P=N/A,  N=0, Withdrawn, 
    N=60 --> 10 | Trial primary completion date: Oct 2014 --> Jan 2017 N=20 --> 0 | Suspended --> Withdrawn
  • ||||||||||  Trial completion, Enrollment change:  Autonomic Function in Obstructive Sleep Apnea (clinicaltrials.gov) -  Feb 24, 2017   
    P=N/A,  N=70, Completed, 
    N=20 --> 0 | Suspended --> Withdrawn Active, not recruiting --> Completed | N=90 --> 70
  • ||||||||||  Trial completion, Trial primary completion date:  Sleep and Stent Study: a Multicentre, Prospective Study (clinicaltrials.gov) -  Feb 23, 2017   
    P=N/A,  N=1815, Completed, 
    Active, not recruiting --> Completed | N=90 --> 70 Active, not recruiting --> Completed | Trial primary completion date: Sep 2018 --> Sep 2015
  • ||||||||||  Trial completion, Trial primary completion date:  GESAP: Management of Patients With Suspected of Sleep Apnea-hypopnea Syndrome From Primary Care (clinicaltrials.gov) -  Feb 14, 2017   
    P=N/A,  N=280, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Sep 2018 --> Sep 2015 Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Dec 2015
  • ||||||||||  Phase classification:  The Effect of Aerobic Interval Training on Obstructive Sleep Apnea (clinicaltrials.gov) -  Feb 13, 2017   
    P=N/A,  N=30, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Dec 2015 Phase classification: P1 --> P=N/A
  • ||||||||||  Trial completion, HEOR, Head-to-Head, Cost effectiveness:  HRP-M: Cost-effectiveness of Home Respiratory Polygraphy (clinicaltrials.gov) -  Feb 8, 2017   
    P3,  N=440, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date, Surgery:  PAC-IC-SAOS Obstructive Sleep Apnea Syndrome and Ventricular Function (clinicaltrials.gov) -  Feb 3, 2017   
    P=N/A,  N=17, Completed, 
    Trial primary completion date: Dec 2016 --> Dec 2017 Recruiting --> Completed | N=69 --> 17 | Trial primary completion date: Jan 2018 --> Sep 2016
  • ||||||||||  Trial completion, Trial primary completion date, Surgery:  PAC-IC-SAS Pilot Study - Central Sleep Apneas Syndrome and Ventricular Function (clinicaltrials.gov) -  Feb 2, 2017   
    P=N/A,  N=10, Completed, 
    Trial primary completion date: Mar 2017 --> Nov 2017 Recruiting --> Completed | Trial primary completion date: Dec 2016 --> May 2015
  • ||||||||||  Trial completion, Phase classification, Trial primary completion date:  Renal Denervation in Patients With Resistant Hypertension and Obstructive Sleep Apnea (clinicaltrials.gov) -  Jan 26, 2017   
    P=N/A,  N=60, Completed, 
    Recruiting --> Completed | Trial primary completion date: Dec 2016 --> May 2015 Active, not recruiting --> Completed | Phase classification: P2 --> PN/A | Trial primary completion date: Mar 2015 --> Feb 2016
  • ||||||||||  Enrollment open, Phase classification, HEOR, Cost effectiveness:  Home Nasal Pressure for Sleep Apnea Management in Primary Case (clinicaltrials.gov) -  Jan 24, 2017   
    P=N/A,  N=280, Recruiting, 
    Recruiting --> Completed | Trial primary completion date: Jan 2015 --> Jun 2016 Not yet recruiting --> Recruiting | Phase classification: P2 --> PN/A
  • ||||||||||  Enrollment closed, Enrollment change, Trial primary completion date:  Holter: Electrocardiography Data Analysis in Sleep Disorders (clinicaltrials.gov) -  Jan 10, 2017   
    P=N/A,  N=120, Active, not recruiting, 
    N=175 --> 0 | Terminated --> Withdrawn Recruiting --> Active, not recruiting | N=300 --> 120 | Trial primary completion date: Mar 2015 --> Mar 2018